It is important to note that G9a is overexpressed in a number of cancers, including esophageal squamous cell carcinoma, hepatocellular carcinoma, aggressive lung cancer, brain cancer, multiple myeloma, and aggressive ovarian carcinoma (Casciello et al., 2015[4]). This evidence concerns the gene EHMT2 and cancer.